Business · 24/02/2009

FDA Hosts Public Workshop on Clinical Trial Design for HAP and VAP

The FDA is hosting a public workshop to discuss clinical trial design for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), in collaboration with several medical organizations. The workshop aims to gather input from healthcare providers, academia, and industry on various aspects of antimicrobial drug development for HAP and VAP.